VNDA
Vanda Pharmaceuticals Inc
5.00$
-3.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.6% | +4.8% | +6.3% | -5.6% | +11.6% | -5.9% | +5.1% | +7.0% | +1.7% | -9.6% | -2.3% | – | |
| – | +13.0% | +57.7% | -17.8% | -43.1% | +1.5% | +35.9% | +27.4% | -34.2% | +29.8% | +34.3% | -30.8% | – | |
| – | +16.9% | +0.5% | +9.5% | -1.9% | +12.2% | -8.1% | +3.4% | +10.8% | +0.1% | -12.8% | +0.9% | – | |
| – | +46.6% | -13.1% | -21.2% | +0.7% | +18.3% | +80.0% | -38.4% | +2.6% | +28.6% | -2.0% | +30.0% | – | |
| – | -6.7% | +30.2% | +31.2% | -4.8% | -0.5% | +34.0% | +29.0% | -6.7% | +4.5% | +8.5% | +5.1% | – | |
| – | +17.1% | +4.8% | +9.6% | -0.1% | +8.5% | +49.6% | -4.9% | -2.3% | +10.8% | +3.3% | +14.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -170.1% | – | – | – | – | – | – | – | -99.9% | -9.8% | – | |
| – | -1,851.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -209.3% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.